Haleon, a consumer healthcare firm, has announced an investment of £130 million ($169 million) to build an innovation centre in Weybridge, UK. The new facility will reportedly feature state-of-the-art, digitally enabled research laboratories and a dedicated consumer behaviour research facility, employing 450 staff. This new facility intends to support Haleon’s oral health portfolio, including brands like Sensodyne, Polident/Poligrip, Aquafresh and Corsodyl. Commenting on the move, Haleon CEO Brian McNamara said: …
Loading tweets...
Haleon
Haleon, a consumer healthcare firm, has announced it has entered into an agreement to sell its nicotine replacement therapy business outside of the US to Indian multinational pharmaceutical company Dr Reddy’s for £500 million ($633 million). The portfolio set to be acquired includes the brands Nicotinell, Nicabate, Habitrol, and Thrive, inclusive of all formats such as lozenges, patches and gums, as well as pipeline products across over 30 markets. Commenting …
Yellow Wood Partners, a private equity firm based in Boston, USA, has announced that its portfolio company Suave Brands has signed a binding offer to acquire the lip balm brand ChapStick from Haleon, a consumer healthcare firm, for €468 million ($519.6 million). ChapStick lip balm first debuted in the 1880s and later diversified its product range with innovative new ingredients, skincare benefits, and flavours, Yellow Wood Partners said in a …
Copyright © 2020. Gama. All rights reserved. Privacy Policy | Legal Notice
Haleon Archives - Gama